Blood clot worries spark switch to Pfizer jab in under-50s

Pfizer is now the preferred vaccine for people aged under 50 after Australia’s medical experts held a lengthy meeting yesterday to discuss a rare but serious blood clotting side effect linked to the AstraZeneca vaccine.